Canada's main stock index fell on Friday, as materials stocks declined and signs of credit stress at U.S. regional lenders sparked concerns. The TSX dwindled 350.32 points, or 1.2%, to 30,108.48.
Hit a new 52-Week High of $34.40. Altius reported it expects to report Q3 2025 attributable royalty revenue of approximately ...
Canada's main stock index opened lower on Friday, extending previous session's decline, as signs of credit stress at U.S. regional lenders sparked concerns. The TSX watched its losing streak lengthen, ...
Despite this week’s UK sanctions on the only Chinese terminal importing LNG from Russia’s Arctic LNG 2 project, a new cargo ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for ...
Wrap Technologies, Inc. (NASDAQ: WRAP), a global leader in innovative public safety and unmanned aerial systems solutions, today unveiled the first known U.S. commercially available non-lethal drone ...
Meta Platforms (META) has introduced parental controls for children and teenagers interacting with artificial intelligence (A ...
Sonoma, Inc. (NYSE: WSM)—the world’s largest digital-first, design-led and sustainable home retailer—announced today, the opening of a new retail location in Salt Lake City, Utah. Located in Salt Lake ...
Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on developing ...
Webster Financial Corporation (NYSE: WBS) shares progressed Friday, as the holding company for Webster Bank, N.A., announced net income applicable to common stockholders of $254.1 million, or $1.54 ...
Prices for leading cryptocurrencies such as Bitcoin (BTC) and Ethereum (ETH) have fallen to their lowest levels in more than three months as sentiment among jittery investors turns bearish. Bitcoin is ...
Baystreet.ca News Commentary – Biomarker-driven approaches enhance the likelihood of identifying optimal patient populations and streamline trials through accelerated approval pathways, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results